This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Discover index funds with standout Sharpe ratios over the last ten years and learn how risk-adjusted performance translates into better risk management.
28,172 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A crisis-focused charity is pivoting to support TSA officers unpaid during a partial government shutdown. The effort ...
Pay transparency is surfacing a bigger problem: firms publish pay ranges but struggle to explain how they set actual ...
Cathie Wood’s Ark bets have shaped market buzz for years. This piece explains what it could mean when investment's ca...
Former President Donald Trump said he would attend Game 3 of the NBA Finals but urged ordinary fans to stream it inst...
A 63-year-old, single worker faces the classic Social Security dilemma: claim now for $1,750 monthly or delay to 70 f...
A 67-year-old homeowner with two mortgage-free homes worth millions weighs a HELOC to cover unexpected bills as rates...
A high-profile lawsuit highlights how quickly legal exposure can strain a creator’s finances. Learn practical steps t...
Alumis stock over 300% has turned heads after a big healthcare investor trimmed its stake. This article breaks down w...
A major U.S. player in rare-earth magnets has fallen from its peak as policy shifts promise supply-chain resilience. ...
Linked Polymarket accounts reportedly racked up millions on Iran-related bets, prompting questions about insider info...
As July 18, 2026 approaches, the GENIUS Act deadline accelerates rulemaking for stablecoin issuers. Regulators from T...